Cargando…

Validation of onchocerciasis biomarker N-acetyltyramine-O-glucuronide (NATOG)

The Neglected Tropical Disease onchocerciasis is a parasitic disease. Despite many control programmes by the World Health Organization (WHO), large communities in West and Central Africa are still affected. Besides logistic challenges during biannual mass drug administration, the lack of a robust, p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Globisch, Daniel, Eubanks, Lisa M., Shirey, Ryan J., Pfarr, Kenneth M., Wanji, Samuel, Debrah, Alexander Y., Hoerauf, Achim, Janda, Kim D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science Ltd 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510726/ https://www.ncbi.nlm.nih.gov/pubmed/28600214 http://dx.doi.org/10.1016/j.bmcl.2017.05.082

Ejemplares similares

Evaluation of the diagnostic potential of urinary N-Acetyltyramine-O,β-glucuronide (NATOG) as diagnostic biomarker for Onchocerca volvulus infection
por: Lagatie, Ole, et al.
Publicado: (2016)

Urinary N-acetyltyramine-O,β-glucuronide in Persons with Onchocerciasis-Associated Epilepsy
por: Hotterbeekx, An, et al.
Publicado: (2020)

Noninvasive Urine Biomarker Lateral Flow Immunoassay for Monitoring Active Onchocerciasis
por: Shirey, Ryan J., et al.
Publicado: (2018)

Onchocerciasis Control: Vision for the Future from a Ghanian perspective
por: Taylor, Mark J, et al.
Publicado: (2009)

Repurposing of approved drugs from the human pharmacopoeia to target Wolbachia endosymbionts of onchocerciasis and lymphatic filariasis
por: Johnston, Kelly L., et al.
Publicado: (2014)

Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin
por: Debrah, Alexander Yaw, et al.
Publicado: (2006)

Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study
por: Hoerauf, Achim, et al.
Publicado: (2007)

Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study
por: Hoerauf, Achim, et al.
Publicado: (2008)

Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon
por: Wanji, Samuel, et al.
Publicado: (2009)

The Mbam drainage system and onchocerciasis transmission post ivermectin mass drug administration (MDA) campaign, Cameroon
por: Abong, Raphael Awah, et al.
Publicado: (2021)

Whole blood transcriptome analysis in onchocerciasis
por: Lagatie, Ole, et al.
Publicado: (2022)

Identification of the onchocerciasis vector in the Kakoi-Koda focus of the Democratic Republic of Congo
por: Post, Rory J., et al.
Publicado: (2022)

Retarded Onchocerca volvulus L1 to L3 larval development in the Simulium damnosum vector after anti-wolbachial treatment of the human host
por: Albers, Anna, et al.
Publicado: (2012)

The Annotated Genome of Wolbachia from the Filarial Nematode Brugia malayi: What It Means for Progress in Antifilarial Medicine
por: Pfarr, Kenneth, et al.
Publicado: (2005)

Hyperreactive Onchocerciasis is Characterized by a Combination of Th17-Th2 Immune Responses and Reduced Regulatory T Cells
por: Katawa, Gnatoulma, et al.
Publicado: (2015)

Filariasis and lymphoedema
por: PFARR, K M, et al.
Publicado: (2009)

Frequent detection of worm movements in onchocercal nodules by ultrasonography
por: Mand, Sabine, et al.
Publicado: (2005)

Wuchereria bancrofti-infected individuals harbor distinct IL-10-producing regulatory B and T cell subsets which are affected by anti-filarial treatment
por: Ritter, Manuel, et al.
Publicado: (2019)

Immunoepidemiological Profiling of Onchocerciasis Patients Reveals Associations with Microfilaria Loads and Ivermectin Intake on Both Individual and Community Levels
por: Arndts, Kathrin, et al.
Publicado: (2014)

Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis
por: TAYLOR, MARK J., et al.
Publicado: (2014)

Metabolomics-Based Discovery of Diagnostic Biomarkers for Onchocerciasis
por: Denery, Judith R., et al.
Publicado: (2010)

Reduced Type 2 Innate Lymphocyte Cell Frequencies in Patent Wuchereria bancrofti-Infected Individuals
por: Tamadaho, Ruth S. E., et al.
Publicado: (2023)

Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical Trial
por: Batsa Debrah, Linda, et al.
Publicado: (2020)

Extracellular Onchocerca-derived small RNAs in host nodules and blood
por: Quintana, Juan F, et al.
Publicado: (2015)

Immunohistology of ectopic secondary lymph follicles in subcutaneous nodules from patients with hyperreactive onchocerciasis (sowda)
por: Brattig, Norbert W., et al.
Publicado: (2010)

Elimination of African Onchocerciasis: Modeling the Impact of Increasing the Frequency of Ivermectin Mass Treatment
por: Coffeng, Luc E., et al.
Publicado: (2014)

Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria
por: Brieger, William R, et al.
Publicado: (2011)

Comparison of Doxycycline, Minocycline, Doxycycline plus Albendazole and Albendazole Alone in Their Efficacy against Onchocerciasis in a Randomized, Open-Label, Pilot Trial
por: Klarmann-Schulz, Ute, et al.
Publicado: (2017)

Macrofilaricidal Activity in Wuchereria bancrofti after 2 Weeks Treatment with a Combination of Rifampicin plus Doxycycline
por: Debrah, Alexander Yaw, et al.
Publicado: (2011)

Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis
por: Tamarozzi, Francesca, et al.
Publicado: (2012)

Single nucleotide polymorphisms in the angiogenic and lymphangiogenic pathways are associated with lymphedema caused by Wuchereria bancrofti
por: Debrah, Linda Batsa, et al.
Publicado: (2017)

Morbidity management and surveillance of lymphatic filariasis disease and acute dermatolymphangioadenitis attacks using a mobile phone-based tool by community health volunteers in Ghana
por: Debrah, Linda Batsa, et al.
Publicado: (2020)

Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon
por: Wanji, Samuel, et al.
Publicado: (2005)

Projected Number of People With Onchocerciasis–Loiasis Coinfection in Africa, 1995 to 2025
por: Vinkeles Melchers, Natalie V S, et al.
Publicado: (2020)

Epidemiology of Mansonella perstans in the middle belt of Ghana
por: Debrah, Linda Batsa, et al.
Publicado: (2017)

A qPCR to quantify Wolbachia from few Onchocerca volvulus microfilariae as a surrogate for adult worm histology in clinical trials of antiwolbachial drugs
por: Schlabe, Stefan, et al.
Publicado: (2022)

Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control
por: Thomson, Madeleine C, et al.
Publicado: (2004)

Urine metabolites for the identification of Onchocerca volvulus infections in patients from Cameroon
por: Wewer, Vera, et al.
Publicado: (2021)

Doxycycline Reduces Plasma VEGF-C/sVEGFR-3 and Improves Pathology in Lymphatic Filariasis
por: Debrah, Alexander Yaw, et al.
Publicado: (2006)

Onchocerciasis
Publicado: (1911)

Cannot write session to /tmp/vufind_sessions/sess_21gvosdfnidqoprovvdfe4c0lr